IL166114A0 - Long-acting controlled-release pharmaceutical preparation for use in the oral cavity - Google Patents

Long-acting controlled-release pharmaceutical preparation for use in the oral cavity

Info

Publication number
IL166114A0
IL166114A0 IL16611405A IL16611405A IL166114A0 IL 166114 A0 IL166114 A0 IL 166114A0 IL 16611405 A IL16611405 A IL 16611405A IL 16611405 A IL16611405 A IL 16611405A IL 166114 A0 IL166114 A0 IL 166114A0
Authority
IL
Israel
Prior art keywords
long
oral cavity
pharmaceutical preparation
release pharmaceutical
acting controlled
Prior art date
Application number
IL16611405A
Other languages
English (en)
Original Assignee
Calcident Active Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Calcident Active Ltd filed Critical Calcident Active Ltd
Priority to IL16611405A priority Critical patent/IL166114A0/xx
Priority to CA002593094A priority patent/CA2593094A1/fr
Priority to US11/794,168 priority patent/US20080085248A1/en
Priority to EP05820450A priority patent/EP1841412A2/fr
Priority to PCT/IL2005/001385 priority patent/WO2006072940A2/fr
Publication of IL166114A0 publication Critical patent/IL166114A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Birds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL16611405A 2005-01-03 2005-01-03 Long-acting controlled-release pharmaceutical preparation for use in the oral cavity IL166114A0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
IL16611405A IL166114A0 (en) 2005-01-03 2005-01-03 Long-acting controlled-release pharmaceutical preparation for use in the oral cavity
CA002593094A CA2593094A1 (fr) 2005-01-03 2005-12-28 Preparation pharmaceutique a liberation prolongee et controlee destinee a etre utilisee dans la cavite buccale
US11/794,168 US20080085248A1 (en) 2005-01-03 2005-12-28 Controlled Long Acting Release Pharmaceutical Preparation For Use In The Oral Cavity
EP05820450A EP1841412A2 (fr) 2005-01-03 2005-12-28 Preparation pharmaceutique a liberation prolongee et controlee destinee a etre utilisee dans la cavite buccale
PCT/IL2005/001385 WO2006072940A2 (fr) 2005-01-03 2005-12-28 Preparation pharmaceutique a liberation prolongee et controlee destinee a etre utilisee dans la cavite buccale

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL16611405A IL166114A0 (en) 2005-01-03 2005-01-03 Long-acting controlled-release pharmaceutical preparation for use in the oral cavity

Publications (1)

Publication Number Publication Date
IL166114A0 true IL166114A0 (en) 2006-01-15

Family

ID=36647857

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16611405A IL166114A0 (en) 2005-01-03 2005-01-03 Long-acting controlled-release pharmaceutical preparation for use in the oral cavity

Country Status (5)

Country Link
US (1) US20080085248A1 (fr)
EP (1) EP1841412A2 (fr)
CA (1) CA2593094A1 (fr)
IL (1) IL166114A0 (fr)
WO (1) WO2006072940A2 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007095524A2 (fr) * 2006-02-13 2007-08-23 Sonoma Holdings Llc Traitement passif par solute a liberation modifiee
US20100305071A1 (en) * 2007-08-30 2010-12-02 Prelief Inc. Methods for improving healing of an oral lesion using a glycerophosphate salt
EP2470179B1 (fr) * 2009-08-26 2017-11-29 Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. Systèmes de délivrance à libération prolongée pour la prévention et le traitement de cancers de la tête et du cou
RS55372B1 (sr) 2011-04-29 2017-03-31 Moberg Pharma Ab Farmaceutske kompozicije koje sadrže lokalni anestetik kao što je bupivakain, za lokalnu administraciju u ustima ili grlu
KR101950663B1 (ko) * 2011-09-28 2019-02-20 라이온 가부시키가이샤 구강용 조성물
CN102697802A (zh) * 2012-06-29 2012-10-03 广东仙乐制药有限公司 一种钙加钙制剂及其制备方法
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
AU2014266070A1 (en) * 2013-05-17 2015-12-10 Alequident Limited Oral healthcare product
CA3206208A1 (fr) 2013-12-31 2015-07-09 Rapamycin Holdings, Llc Preparations orales de nanoparticules de rapamycine, et utilisation
EP2959884A1 (fr) * 2014-06-24 2015-12-30 Pamela Fialka Nouvelle composition pour la reminéralisation des dents
KR101683635B1 (ko) 2014-12-29 2016-12-09 가천대학교 산학협력단 락테이트 금속염을 포함하는 암 치료용 약학 조성물
EP3737363A4 (fr) 2018-01-12 2021-10-20 Metimedi Pharmaceuticals Co., Ltd Méthodes de traitement de maladies inflammatoires chroniques
EP3797818B1 (fr) * 2018-05-23 2023-01-18 Shanghai WD Pharmaceutical Co., Ltd Système à libération contrôlée d'un principe actif pharmaceutique et son procédé de préparation
US11911513B2 (en) 2018-05-23 2024-02-27 Shanghai Wd Pharmaceutical Co., Ltd Controlled-release system of active pharmaceutical ingredient and preparation method therefor

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3312594A (en) * 1963-06-21 1967-04-04 Squibb & Sons Inc Longlasting troche
US3594467A (en) * 1968-10-09 1971-07-20 Richardson Merrell Inc Long-lasting troche
US3577512A (en) * 1968-10-11 1971-05-04 Nat Patent Dev Corp Sustained release tablets
AU6104973A (en) * 1972-10-13 1975-04-10 Procter & Gamble Remineralization of dental enamel
US4008719A (en) * 1976-02-02 1977-02-22 Alza Corporation Osmotic system having laminar arrangement for programming delivery of active agent
US4450198A (en) * 1980-01-28 1984-05-22 Alza Corporation Microporous film with polymer in pores for regulating passage of fluid
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4340054A (en) * 1980-12-29 1982-07-20 Alza Corporation Dispenser for delivering fluids and solids
US4519801A (en) * 1982-07-12 1985-05-28 Alza Corporation Osmotic device with wall comprising cellulose ether and permeability enhancer
US4485805A (en) * 1982-08-24 1984-12-04 Gunther Pacific Limited Of Hong Kong Weight loss device and method
CA1208558A (fr) * 1982-10-07 1986-07-29 Kazuo Kigasawa Medicament oral
US4681544A (en) * 1983-01-13 1987-07-21 Anthony Albert J Oral pack retention system
US4612008A (en) * 1983-05-11 1986-09-16 Alza Corporation Osmotic device with dual thermodynamic activity
US4783337A (en) * 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
US4765989A (en) * 1983-05-11 1988-08-23 Alza Corporation Osmotic device for administering certain drugs
US4741700A (en) * 1986-07-16 1988-05-03 Barabe David J Dental breath freshening device
US4892739A (en) * 1988-04-25 1990-01-09 Ciba-Geigy Corporation Osmotic continuous dispensing oral delivery system containing a pharmaceutically acceptable active agent having a improved core membrane adhesion properties
US5137449A (en) * 1989-03-20 1992-08-11 Johnson & Johnson Consumer Products, Inc. Intraoral medication releasing system
US5049077A (en) * 1989-03-20 1991-09-17 Johnson & Johnson Consumer Products, Inc. Intraoral medication releasing system
US5156845A (en) * 1990-05-04 1992-10-20 Colgate-Palmolive Company Dry mouth lozenge
US6716454B2 (en) * 1994-09-23 2004-04-06 Laboratorie Innothera, Société Anonyme Therapeutic combination of vitamin and calcium in unitary galenic tablet form, a method of obtaining it, and the use thereof
WO1998013013A1 (fr) * 1996-09-27 1998-04-02 Enamelon, Inc. Produits et procedes ameliores de remineralisation et de prevention de la demineralisation des dents
US6106862A (en) * 1998-08-13 2000-08-22 Andrx Corporation Once daily analgesic tablet
US6440394B2 (en) * 1999-06-01 2002-08-27 Church & Dwight, Co., Inc. Remineralizing-mineralizing oral products containing discrete cationic and anionic agglomerate components and method of use
US20030215498A1 (en) * 2002-05-17 2003-11-20 Harland Ronald S. Rapidly disintegrating comressed tablets comprising biologically active compounds
NZ522071A (en) * 2002-10-18 2005-07-29 Patrick Joseph Silcock Hydrolysed casein phosphoprotein preparations for bioactive metal ion delivery and teeth remineralisation

Also Published As

Publication number Publication date
CA2593094A1 (fr) 2006-07-13
WO2006072940A2 (fr) 2006-07-13
US20080085248A1 (en) 2008-04-10
EP1841412A2 (fr) 2007-10-10
WO2006072940A3 (fr) 2006-12-14

Similar Documents

Publication Publication Date Title
EP1757273A4 (fr) Preparation pour administration orale
IL177566A0 (en) Pharmaceutical formulations
HK1129590A1 (en) Multiple unit type sustained release oral formulation and process for the preparation thereof
GB0426301D0 (en) Pharmaceutical formulations
ZA200705530B (en) Sustained release pharmaceutical formulations
ZA200802947B (en) Stable pharmaceutical composition comprising a pyrimidine-sulfamide
EP1731183A4 (fr) Préparation pharmaceutique solide pour dialyse
IL183929A0 (en) Use of inerferon - ?? in the preparation of a medicament
EP1961413A4 (fr) Comprimé oral à désintégration rapide
EP1916251A4 (fr) Sels d érianine, leurs procédés de préparation et compositions pharmaceutiques contenant ceux-ci
EP1941896A4 (fr) Composition contenant un dipeptide pour administration orale
IL166114A0 (en) Long-acting controlled-release pharmaceutical preparation for use in the oral cavity
GB0423800D0 (en) New pharmaceutical formulations
GB0416397D0 (en) Pharmaceutical formulations
HK1105358A1 (en) Solid pharmaceutical formulation
HK1092734A1 (en) Oral formulation for twice-daily administration
ZA200707910B (en) Contraceptive pharmaceutical preparation
EP1614417A4 (fr) Preparation solide pour l'usage par voie orale
GB0406048D0 (en) Drug formulations
EP1652522A4 (fr) Comprime a liberation prolongee pour l'administration par voie orale
EP1716865A4 (fr) Preparation pharmaceutique contenant de la paraoxonase
EP1864664A4 (fr) Preparation pharmaceutique
HK1094676A1 (en) Solid pharmaceutical preparation form
PL373776A1 (en) Oral pharmaceutical compound
GB0506018D0 (en) Preparation for oral administration